EUVIMEDEUVIMED entdecken
Crossref

Role of gangliosides in prostate pathology

Ilinca Nicolae, Corina-Daniela Ene, Simona Roxana Georgescu

Romanian Journal of Infectious Diseases · 2016

DOI: 10.37897/rjid.2016.1.2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Romanian Journal of Infectious Diseases, 2016. Verfasst von Ilinca Nicolae und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Molecular pathology of benign prostatic hyperplasia is multifactorial and involves endocrine, biochemical, immunological interactions. The mechanisms involved in the onset and progression of benign prostatic hyperplasia are: infections, 50 years of age, hormones and neurotransmitters imbalances, inflammation, oxidative stress. The potential role of glycosylation in the pathogenesis of prostate disease has been neglected. In this study we documented the profile of gangliosides in normal and pathological prostatic tissues together with the pathologic changes seen in the level of extracellular gangliosides in patients with prostate pathology. Analysis of the data in the literature suggests that gangliosides may represent immunologic markers useful in the differential diagnosis between prostate cancer and benign prostatic hyperplasia.

Zitieren

APA

Nicolae, I., Ene, C., & Georgescu, S. R. (2016). Role of gangliosides in prostate pathology. Romanian Journal of Infectious Diseases. https://doi.org/10.37897/rjid.2016.1.2

Vancouver

Nicolae I, Ene C, Georgescu SR. Role of gangliosides in prostate pathology. Romanian Journal of Infectious Diseases. 2016. doi:10.37897/rjid.2016.1.2

BibTeX
@article{Nicolae2016,
  author = {Nicolae, Ilinca and Ene, Corina-Daniela and Georgescu, Simona Roxana},
  title = {Role of gangliosides in prostate pathology},
  journal = {Romanian Journal of Infectious Diseases},
  year = {2016},
  doi = {10.37897/rjid.2016.1.2}
}
Kostenlos starten →